Assessment of peripheral vascular effects of antimigraine drugs in humans.
The vascular beds of the forearm and finger can be used to study the peripheral effects of antimigraine drugs under normal and pathologic circumstances. We have investigated the novel antimigraine drug sumatriptan, a selective agonist for 5HT1 receptors. Its antimigraine effect may be attributed, at least in part, to constriction of cranial arteriovenous anastomoses (AVAs). In assessing the peripheral vascular effects of sumatriptan we used a forearm and finger blood flow model. Forearm blood flow (FBF) is mainly determined by resistance vessels, whereas finger blood flow (FiBF) mainly involves skin vessels, which contain many AVAs. Changes in FBF and FiBF can be assessed using venous occlusion plethysmography. Changes in AVA flow are determined by measuring the patency of the vascular beds of the forearm and hand to well-defined radiolabelled microspheres, which are injected into the brachial artery. We report the effects of sumatriptan on FBF, FiBF and AVA flow when administered into the brachial artery of healthy volunteers, and discuss the peripheral vascular effects of therapeutic doses of sumatriptan when given subcutaneously in migraine patients during and between attacks.
van Es
N M
NM
Department of Nephrolog, University Hospital Leiden, The Netherlands.
Bruning
T A
TA
Camps
J
J
Chang
P C
PC
Blauw
G J
GJ
Ferrari
M D
MD
Saxena
P R
PR
van Zwieten
P A
PA
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005385:Fingers / Q000098:blood supply*; D005542:Forearm / Q000098:blood supply*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D010991:Plethysmography; D012039:Regional Blood Flow; D018170:Sumatriptan / Q000627:therapeutic use*
D018170:Sumatriptan